Peter McNamara

Company: Tectonic Therapeutic

Job title: Chief Scientific Officer

Seminars:

Discovery of Therapeutic Antibodies that Target Specific GPCRs Using a Novel Discovery Platform 5:30 pm

Showcasing GEODETM, a validated discovery platform which enables reproducible discovery of GPCR-targeted biologics Leveraging a robust pipeline of 5 validated targets across a range of indications with the lead program entering the clinic in 2023 Displaying expression and purification technology, in-vitro yeast display of proprietary fully human diverse Ab libraries, and proprietary antigen formats for…Read more

day: Day One